{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:08:31Z","timestamp":1790507311179,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-102032-B-I00"],"award-info":[{"award-number":["RTI2018-102032-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00553","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T04:17:23Z","timestamp":1587097043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds"],"prefix":"10.3389","volume":"11","author":[{"given":"Migl\u00eb","family":"\u017diemyt\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Rodr\u00edguez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda P.","family":"Ventero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda D.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/srep46068","article-title":"Targeting microbial biofilms using Ficin, a nonspecific plant protease.","volume":"7","author":"Baidamshina","year":"2017","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijantimicag.2013.05.019","article-title":"Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.","volume":"42","author":"Baldoni","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrd4000","article-title":"Applying insights from biofilm biology to drug development-can a new approach be developed?","volume":"12","author":"Bjarnsholt","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.rmed.2016.06.015","article-title":"The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections.","volume":"117","author":"Blasi","year":"2016","journal-title":"Respir. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1381612820666140905114627","article-title":"Quorum sensing inhibitors as anti-biofilm agents.","volume":"21","author":"Brackman","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B6","author":"Calcagno","year":"2013","journal-title":"glmulti"},{"key":"B7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase.","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1742-1241.2007.01318.x","article-title":"Dalbavancin: a novel antimicrobial.","volume":"61","author":"Chen","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"B9","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.3390\/ijms140918488","article-title":"Novel strategies for the prevention and treatment of biofilm related infections.","volume":"14","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3947\/ic.2016.48.4.267","article-title":"Treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"48","author":"Choo","year":"2016","journal-title":"Infect. Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/2049-632X.12141","article-title":"Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.","volume":"70","author":"Chung","year":"2014","journal-title":"Pathog. Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17310-4","article-title":"N-acetylcysteine-functionalized coating avoids bacterial adhesion and biofilm formation.","volume":"7","author":"Costa","year":"2017","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jinf.2004.05.006","article-title":"Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo.","volume":"50","author":"Darouiche","year":"2005","journal-title":"J. Infect."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.114901","article-title":"In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times.","volume":"96","author":"Di Pilato","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B15","first-page":"2942","article-title":"N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review.","volume":"18","author":"Dinicola","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B16","year":"2018","journal-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version"},{"key":"B17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2016.05.009","article-title":"In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.","volume":"85","author":"Fern\u00e1ndez","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B18","first-page":"1","author":"Ferrer","year":"","journal-title":"App. Note N\u00b017. Studying Bacterial Biofilms Using Cellular Impedance. xCELLigence <sup>\u00ae<\/sup>Real-time cell analyzers."},{"key":"B19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jam.13368","article-title":"Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis.","volume":"122","author":"Ferrer","year":"","journal-title":"J. Appl. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms5020015","article-title":"Approaches to dispersing medical biofilms.","volume":"5","author":"Fleming","year":"2017","journal-title":"Microorganisms"},{"key":"B21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix.","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.5435\/JAAOS-D-16-00636","article-title":"Staphylococcal biofilms and immune polarization during prosthetic joint infection.","volume":"1","author":"Gries","year":"2017","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01632","article-title":"Real-time assessment of Staphylococcus aureus biofilm disruption by phage-derived proteins.","volume":"8","author":"Guti\u00e9rrez","year":"2017","journal-title":"Front. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria.","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections.","volume":"69","author":"Jacqueline","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/AAC.49.6.2467-2473.2005","article-title":"Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms.","volume":"49","author":"Jefferson","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0022034509359403","article-title":"Biofilm dispersal: mechanisms. clinical implications, and potential therapeutic uses.","volume":"89","author":"Kaplan","year":"2010","journal-title":"J. Dent. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10096-016-2845-z","article-title":"Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).","volume":"36","author":"Knafl","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05178-3","article-title":"Mechanistic action of weak acid drugs on biofilms.","volume":"7","author":"Kundukad","year":"2017","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28006-8","article-title":"Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.","volume":"8","author":"Kussmann","year":"2018","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/s41564-019-0536-0","article-title":"Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate.","volume":"4","author":"Lopatkin","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1128\/AAC.01251-16","article-title":"Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm.","volume":"60","author":"Meeker","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/mmi.13634","article-title":"Staphylococcus aureus biofilm: a complex developmental organism.","volume":"104","author":"Moormeier","year":"2017","journal-title":"Mol. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-med-042711-140023","article-title":"Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity.","volume":"64","author":"Otto","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-94-007-0940-9_22","article-title":"Inhibition of bacterial adhesion on medical devices.","volume":"715","author":"Rodrigues","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","article-title":"Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action.","volume":"9","author":"Roy","year":"2018","journal-title":"Virulence"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1086\/379015","article-title":"Once-Weekly Dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.","volume":"37","author":"Seltzer","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.0.3.248\/s0167-7012(00)00122-6","article-title":"A modified microtiter-plate test for quantification of staphylococcal biofilm formation.","author":"Stepanovic","year":"2000"},{"key":"B40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-8237.167866","article-title":"Antibiotic resistance of bacteria in biofilms.","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-240","article-title":"Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China.","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02175-18","article-title":"Nitric oxide and iron signaling cues have opposing effects on biofilm development in Pseudomonas aeruginosa.","volume":"85","author":"Zhu","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01746-18","article-title":"Role of rifampin against staphylococcal biofilm infections in vitro, in animal models, and in orthopedic-device-related infections.","volume":"63","author":"Zimmerli","year":"2019","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T04:17:25Z","timestamp":1587097045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":43,"alternative-id":["10.3389\/fmicb.2020.00553"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00553","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"article-number":"553"}}